http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Entera Bio reports bone density gains in early menopause trial
-
Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women
-
Slam Frank Announces Two-Week Extension as Creator and "Master Troll" (NYT) Andrew Fox Continues in the Lead Role
-
iMD Companies Cloud Mining Cryptocurrency Update
-
Intelligent Bio Solutions secures UK contract with industrial service provider
-
Duke Robotics Releases Updated Corporate Presentation Highlighting Strategic Momentum and Commercial Expansion Strategies
-
Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider
-
Riverbed Revolutionizes DEX with Aternity Self-Service Powered by Agentic AI
-
Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes
-
Legendary Reggae Artist Maxi Priest and Dancehall Superstar Sean Paul "Feel So Alive" with Level Vibes Music Launch on Intercept Music
-
Avantor partners with p-Chip to develop digital traceability solutions
-
Avantor® Announces Partnership with p-Chip Corporation to Develop Solutions for Digital Traceability of Smart Consumables
-
ConverSight Debuts QuickStart AI for QuickBooks Online (QBO) at Intuit Connect 2025
-
Gilead to present liver disease data at AASLD conference
-
Cousins Maine Lobster Expands Southwest Footprint Through Multi-Unit Deal
-
Gilead to Showcase Interim Long-Term Efficacy Data for Livdelzi® (Seladelpar) in Primary Biliary Cholangitis (PBC) and Investigational Bulevirtide in Chronic Hepatitis Delta
-
Upexi Welcomes Jon Najarian to the Upexi Advisory Committee
-
Scholar Rock to Report Third Quarter 2025 Financial Results on November 14, 2025
-
PKF O'Connor Davies Ranked as Vault's #1 Internship Program for 2026
-
22nd Century launches VLN cigarettes at 140 Circle K stores in Illinois
-
22nd Century Launches VLN® with Major C-Store Chain, New Marketing Collateral, Continues to Expand State Authorizations
-
BTQ Technologies achieves first quantum-safe signature verification on Solana
-
IMAX Corporation Reports Third Quarter 2025 Results
-
Realbotix Updates Board and Establishes Expertise Advisory Committee
-
U.S. Ski & Snowboard and iCapital® Announce Partnership to Champion Excellence of Teams
-
BTQ Technologies Partners with Bonsol Labs to Achieve Industry-First NIST-Standardized Post-Quantum Cryptography Signature Verification on Solana
-
Beyond Lithium Completes Final Tranche of LIFE Offering and Debt Settlement Transaction
-
Genprex collaborators to present lung cancer gene therapy data at conference
-
Moderna to Host Investor Event - Analyst Day
-
Creator Television® Launches On-Demand Offerings on Plex and Xumo Play
-
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EROTC International Conference on Molecular Target
-
Pacific Ridge Intersects 154.7 m of 0.63% Copper Equivalent or 0.94 g/t Gold Equivalent; Expands Mineralization 270 m to the Northwest
-
REKOR SYSTEMS ANNOUNCES PLAN TO ENTER THE GLOBAL DEEPFAKE DETECTION MARKET
-
Merck to present phase 3 results for oral PCSK9 inhibitor at AHA meeting
-
Merck to Present New Data from Its Innovative Cardio-Pulmonary Pipeline and Portfolio at AHA Scientific Sessions 2025
-
Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets
-
FDA grants priority review for Merck's KEYTRUDA cancer treatments
-
FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each in Combination with Padcev® (enfortumab vedotin-ejfv), for Certain
-
Dow reports third quarter 2025 results
-
The Coupa Network Effect: Saving $14+ Billion Amidst Inflation and Trade Uncertainty
-
/C O R R E C T I O N -- Coupa Software/
-
North Korean Lazarus group targets the drone sector in Europe, likely for espionage, ESET Research discovers
-
Blazpay’s Phase 2 Crypto Presale Surges Past 69% - Investors Rush Before Price Hike
-
Apex Files Permit Applications to Advance Exploration at Rift REE Project, Nebraska
-
Kirkland Lake Discoveries Announces Closing of Non-Brokered Private Placement for $12,721,316
-
No Credit Check Loans from ASAP Finance Have Become a Lifeline for U.S. Borrowers with Bad Credit
-
Franklin Covey to Report Fourth Quarter and Year-End Fiscal 2025 Results
-
Moderna CMV vaccine fails phase 3 trial, development discontinued
-
LendingClub Reports Third Quarter 2025 Results
-
Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint
